The focus of her research was how infection with respiratory viruses, particularly influenza, can damage the host airways and lead to increased incidence of secondary bacterial pneumonia. Additionally, she completed a project to predict length of hospitalization in pediatric patients admitted to the hospital for respiratory infections.

In her spare time, Alexis and her husband Jacob enjoy hiking all over the United States. They have a cat, Bandit, who enjoys looking over the city from their Mexican War Streets apartment. Alexis is also an avid reader.

CRS was fortunate to have Alexis as an intern this past year while she gained a wealth of first-hand experience in clinical trials, regulatory science, and policy reform.

Alethea Wieland, President and Founder states, “We are really proud of our strong internship program with some of the most prestigious universities in Southwestern Pennsylvania, who produce top-notch talent ready for the rigors of industry especially in a therapeutic area we are well known for – respiratory and infectious diseases. Alexis is poised to take on our clinical trial and regulatory consulting programs with the scientific know-how that our clients demand in our project leads.”

David Link, MBA, CRS CEO and Chief Quality and Regulatory Officer adds, “Dr. Jancosko has that wonderful combination of curiosity, fearlessness, and optimism that makes for the proper ingredients necessary to excel in the turbulent business of life sciences.”

About Clinical Research Strategies, LLC:

CRS is a specialty clinical CRO and executive management consulting firm that fits-for-purpose veteran life sciences executives, attorneys, regulatory scientists and strategists, clinical operations, project management, quality assurance engineers, and sales and marketing teams to take on the biggest challenges for start-up, mid-sized, and large life sciences companies, many of whom are developing novel, first-in-class drugs, biologics, diagnostics and medical devices, or software as a medical device (SaMD). Service areas are clinical trials, Functional Service Provider (FSP) models, selection and management of CROs, regulatory compliance strategy and submissions, QMS, EU MDR and GDPR, rescue trials, TMF, risk mitigation and remediation, training high-performing teams, staffing solutions, and decentralized trials.

Indications represented are precision medicine, immuno-oncology, central nervous system, infectious diseases, respiratory diseases, orthopedics, de novo devices, digital health and mobile apps, reproductive health, regenerative medicine, cardiology, major depressive disorder, opioid-sparing pain, cannabis, radiology, wound care, and critical care. CRS is a qualified service provider for federal grants.

Clinical Research Strategies (CRS) requires persons to be authorized to work in the United States and to undergo a background check prior to becoming employed. CRS is an inclusive employer and does not discriminate in employment on the basis of race, color, religion, sex, gender identity, national origin, political affiliation, sexual orientation, marital status, disability, genetic information, age, education, membership in an employee organization, parental status, military service, vaccine status, or other non-merit factor. CRS does not tolerate censorship, surveillance, bullying, intimidation, retaliation, discrimination, or harassment of any kind.

# # #

Media Contact:
Ron MacDonald
Step2 Branding and Design
ronmac@step2branding.com
+1 724.814.4067

Alethea Wieland, President and Founder
Clinical Research Strategies, LLC
alethea@clinicalresearchstrategies.com
+1 724.272.1245

Download this press release as a PDF.